Par-3 Partitioning Defective 3 Homolog (PARD3) (Middle Region) Peptid
Kurzübersicht für Par-3 Partitioning Defective 3 Homolog (PARD3) (Middle Region) Peptid (ABIN8107626)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- PARD3 Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-PARD3 antibody ( ARP42910_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- PARD3 (Par-3 Partitioning Defective 3 Homolog (PARD3))
-
Hintergrund
-
Background Information: PARD proteins, which were first identified in C. elegans, are essential for asymmetric cell division and polarized growth, whereas CDC42 (MIM 116952) mediates the establishment of cell polarity. The CDC42 GTPase, which is controlled by nucleotide exchange
Alternative Symbols: ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2
-
Molekulargewicht
- 151kDa
-
Gen-ID
- 56288
-
NCBI Accession
- NP_062565
-
UniProt
- Q8TEW0
Target
-